Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al

Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1247-9. doi: 10.1002/pds.1872.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adverse Drug Reaction Reporting Systems*
  • Chemical and Drug Induced Liver Injury / etiology*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Liver Failure / chemically induced*
  • Pioglitazone
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*
  • Thiazolidinediones / therapeutic use

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone
  • Pioglitazone